13F-HR 1 w83575e13fvhr.txt BB BIOTECH AG UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 13F Form 13F COVER PAGE Report for Calendar Year or Quarter Ended: December 31, 2002 Check here if Amendment [ ]; Amendment Number: This Amendment (Check only one.): [ ] is a restatement. [ ] adds new holdings entries. Institutional Investment Manager Filing this Report: Name: BB Biotech AG Address: Vordergasse 3 Schaffhausen Switzerland CH-8200 Form 13F File Number: 28-6964 The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables are considered integral parts of this form. Person Signing this Report on Behalf of Reporting Manager: Name: Adrian Bruengger Title: SIGNING AUTHORITY ----------------- Phone: (41-41) 724-5959 Signature, Place, and Date of Signing: /s/ ADRIAN BRUENGGER ----------------------------------- Zug, Switzerland, February 14, 2003 Report Type (Check only one.): [ ] 13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager are reported in this report.) [ ] 13F NOTICE. (Check here if no holdings reported are in this report, and all holdings are reported by other reporting manager(s).) [X] 13F COMBINATION REPORT. (Check here if a portion of the holdings for this reporting manager are reported in this report and a portion are reported by other reporting manager(s).) List of Other Managers Reporting for this Manager: Name Biotech Focus N.V. Biotech Invest N.V. Biotech Target N.V. Biotech Growth N.V. Form 13F SUMMARY PAGE Report Summary: Number of Other Included Managers: 4 Form 13F Information Table Entry Total: 21 Form 13F Information Table Value Total: $983,967 (thousands) List of Other Included Managers: Provide a numbered list of the name(s) and Form 13F file number(s) of all institutional investment managers with respect to which this report is filed, other than the manager filing this report.
No. Name --- ---- 1 Biotech Focus N.V. 2 Biotech Invest N.V. 3 Biotech Target N.V. 4 Biotech Growth N.V.
BB BIOTECH AG FORM 13F INFORMATION TABLE
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 -------------- --------- --------- -------- -------- TITLE OF VALUE SHS OR SH/ PUT/ NAME OF ISSUER CLASS CUSIP (x$1000) PRN AMT PRN CALL -------------- --------- --------- --------- ---------- -------- ---- 3-Dimensional COM 88554W104 9,207 2,850,485 SH Pharmaceuticals, Inc. Adolor Corp. COM 00724X102 21,769 1,565,000 SH Amgen Inc. COM 031162100 355,299 7,350,000 SH Cell Therapeutics, Inc. COM 150934107 6,692 920,500 SH Cubist Pharmaceuticals, COM 229678107 9,218 1,120,000 SH Inc. CV Therapeutics, Inc. COM 126667104 33,947 1,863,147 SH Durect Corporation COM 266605104 4,555 2,254,957 SH Endo Pharmaceuticals COM 29264F205 8,369 1,087,000 SH Enzon Pharmaceuticals, COM 293904108 8,736 522,500 SH Inc. IDEC Pharmaceuticals COM 449370105 184,949 5,575,800 SH IDEC Pharmaceuticals LYON ZERO 449370AD7 23,337 42,000,000 PRN CPN Ligand Pharmaceuticals COM 53220K207 14,459 2,692,500 SH Medicines Company (The) COM 584688105 47,748 2,980,500 SH MedImmune COM 584699102 163,292 6,010,000 SH Neurocrine Biosciences COM 64125C109 34,245 750,000 SH Pozen, Inc. COM 73941U102 14,420 2,800,000 SH Regeneron COM 75886F107 4,442 240,000 SH Pharmaceuticals, Inc. Serono SA ADR 81752M101 6,780 500,000 SH Shire Pharmaceuticals ADR 82481R106 20,779 1,100,000 SH Group PLC Transkaryotic Therapies COM 893735100 6,929 699,900 SH Virologic COM 92823R201 4,795 3,605,004 SH COLUMN 1 COLUMN 6 COLUMN 7 COLUMN 8 -------- ---------- -------- ---------------------- INVESTMENT OTHER VOTING AUTHORITY NAME OF ISSUER DISCRETION MANAGERS SOLE SHARED NONE -------------- ---------- -------- ---------------------- ---- 3-Dimensional DEFINED 3 2,850,485 NONE NONE Pharmaceuticals, Inc. Adolor Corp. DEFINED 3 1,565,000 NONE NONE Amgen Inc. DEFINED 1 7,350,000 NONE NONE Cell Therapeutics, Inc. DEFINED 3 920,500 NONE NONE Cubist Pharmaceuticals, DEFINED 3 1,120,000 NONE NONE Inc. CV Therapeutics, Inc. DEFINED 3 1,863,147 NONE NONE Durect Corporation DEFINED 3 2,254,957 NONE NONE Endo Pharmaceuticals DEFINED 3 1,087,000 NONE NONE Enzon Pharmaceuticals, DEFINED 3 522,500 NONE NONE Inc. IDEC Pharmaceuticals DEFINED 1 5,575,800 NONE NONE IDEC Pharmaceuticals DEFINED 1 42,000,000 NONE NONE Ligand Pharmaceuticals DEFINED 2 2,692,500 NONE NONE Medicines Company (The) DEFINED 4 2,980,500 NONE NONE MedImmune DEFINED 1 6,010,000 NONE NONE Neurocrine Biosciences DEFINED 3 750,000 NONE NONE Pozen, Inc. DEFINED 3 2,800,000 NONE NONE Regeneron DEFINED 3 240,000 NONE NONE Pharmaceuticals, Inc. Serono SA DEFINED 1 500,000 NONE NONE Shire Pharmaceuticals DEFINED 1 1,100,000 NONE NONE Group PLC Transkaryotic Therapies DEFINED 2 699,900 NONE NONE Virologic DEFINED 3 3,605,004 NONE NONE